ATE404192T1 - Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration - Google Patents
Verwendung von nefiracetam zur behandlung von postischemischer neurodegenerationInfo
- Publication number
- ATE404192T1 ATE404192T1 AT01958395T AT01958395T ATE404192T1 AT E404192 T1 ATE404192 T1 AT E404192T1 AT 01958395 T AT01958395 T AT 01958395T AT 01958395 T AT01958395 T AT 01958395T AT E404192 T1 ATE404192 T1 AT E404192T1
- Authority
- AT
- Austria
- Prior art keywords
- nefiracetam
- neurodegeneration
- postischemic
- treat
- stroke
- Prior art date
Links
- NGHTXZCKLWZPGK-UHFFFAOYSA-N nefiracetam Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1C(=O)CCC1 NGHTXZCKLWZPGK-UHFFFAOYSA-N 0.000 title abstract 3
- 229950004663 nefiracetam Drugs 0.000 title abstract 2
- 230000004770 neurodegeneration Effects 0.000 title abstract 2
- 208000006011 Stroke Diseases 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 238000011084 recovery Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2001/007180 WO2003018005A1 (en) | 2001-08-22 | 2001-08-22 | use of nefiracetam for treating neurodegeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE404192T1 true ATE404192T1 (de) | 2008-08-15 |
Family
ID=11737657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01958395T ATE404192T1 (de) | 2001-08-22 | 2001-08-22 | Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20040192759A1 (de) |
| EP (1) | EP1420782B1 (de) |
| JP (1) | JP2005501108A (de) |
| AT (1) | ATE404192T1 (de) |
| CA (1) | CA2457982C (de) |
| DE (1) | DE60135390D1 (de) |
| ES (1) | ES2311537T3 (de) |
| WO (1) | WO2003018005A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060241144A1 (en) * | 2005-04-20 | 2006-10-26 | Albert Cha | Method for treating apathy syndrome |
| RU2329804C2 (ru) * | 2006-03-28 | 2008-07-27 | Валентина Ивановна Ахапкина | Вещество, обладающее нейротропной - нейромодуляторной активностью |
| ES2865504T3 (es) * | 2008-10-16 | 2021-10-15 | Univ Johns Hopkins | Procedimientos y composiciones para la mejora de la función cognitiva |
| US8962676B2 (en) | 2009-10-22 | 2015-02-24 | University College Dublin, National University Of Ireland, Dublin | Causal therapy of diseases or conditions associated with CNS or PNS demyelination |
| EP2533645B1 (de) * | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen |
| EP2919788A4 (de) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | Verfahren und zusammensetzungen zur behandlung von schizophrenie |
| EP3827820A1 (de) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam zur verbesserung der kognitiven funktion |
| WO2014144801A1 (en) | 2013-03-15 | 2014-09-18 | Agenebio Inc. | Methods and compositions for improving cognitive function |
| CN112843005B (zh) | 2015-05-22 | 2023-02-21 | 艾吉因生物股份有限公司 | 左乙拉西坦的延时释放药物组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4749700A (en) * | 1984-10-23 | 1988-06-07 | Nastech Pharmaceutical Co, Inc. | Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same |
| JP3388778B2 (ja) * | 1991-05-02 | 2003-03-24 | 第一製薬株式会社 | 脳血管性痴呆改善剤 |
| CA2067614C (en) * | 1991-05-02 | 2002-07-30 | Eiichi Otomo | Agent for improving dementia |
| AU8131198A (en) * | 1997-07-15 | 1999-02-10 | Daiichi Pharmaceutical Co., Ltd. | Prophylactic or therapeutic agent for amnesia |
| JPH1180027A (ja) * | 1997-09-12 | 1999-03-23 | Dai Ichi Seiyaku Co Ltd | 向知性薬 |
| US6423739B1 (en) * | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
-
2001
- 2001-08-22 ES ES01958395T patent/ES2311537T3/es not_active Expired - Lifetime
- 2001-08-22 WO PCT/JP2001/007180 patent/WO2003018005A1/en not_active Ceased
- 2001-08-22 CA CA002457982A patent/CA2457982C/en not_active Expired - Fee Related
- 2001-08-22 DE DE60135390T patent/DE60135390D1/de not_active Expired - Lifetime
- 2001-08-22 JP JP2003522525A patent/JP2005501108A/ja active Pending
- 2001-08-22 EP EP01958395A patent/EP1420782B1/de not_active Expired - Lifetime
- 2001-08-22 AT AT01958395T patent/ATE404192T1/de not_active IP Right Cessation
- 2001-08-22 US US10/487,320 patent/US20040192759A1/en not_active Abandoned
-
2007
- 2007-09-28 US US11/863,808 patent/US20080076820A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005501108A (ja) | 2005-01-13 |
| DE60135390D1 (de) | 2008-09-25 |
| EP1420782A1 (de) | 2004-05-26 |
| CA2457982A1 (en) | 2003-03-06 |
| ES2311537T3 (es) | 2009-02-16 |
| US20080076820A1 (en) | 2008-03-27 |
| CA2457982C (en) | 2009-11-03 |
| WO2003018005A1 (en) | 2003-03-06 |
| US20040192759A1 (en) | 2004-09-30 |
| EP1420782B1 (de) | 2008-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| ATE269846T1 (de) | N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen | |
| ATE405564T1 (de) | 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten | |
| BG106095A (bg) | Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици | |
| BR0311313A (pt) | Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
| DK1341524T3 (da) | Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel | |
| RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
| DE60233433D1 (de) | PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN | |
| ATE404192T1 (de) | Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration | |
| ATE157871T1 (de) | Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind | |
| DE602004031631D1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
| ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
| BR0104586A (pt) | Método para tratamento de neurodegeneração | |
| DE602004029993D1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
| ATE331523T1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| ATE440835T1 (de) | Heterozyklische harnstoff-derivate für die behandlung von schmerzen. | |
| DE602004025103D1 (de) | Heilkräuterzusammensetzung zur Behandlung von AIDS | |
| DE68916651D1 (de) | Heilmittel zur behandlung von toxoplasmose. | |
| ATE491474T1 (de) | Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor- antagonists | |
| RU2000125000A (ru) | Состав для антисептической обработки кожи рук и операционного поля | |
| DE60327249D1 (de) | Anthranilsäureamide und ihre pharmazeutische verwendung | |
| ATE370733T1 (de) | Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen | |
| ATE284696T1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |